Semax 30mg

Semax (MEHFPGP) is a synthetic heptapeptide analogue of the ACTH(4-10) fragment developed to retain specific peptide-signaling properties while exhibiting a distinct pharmacological profile. Experimental investigations have examined its interactions with melanocortin-associated signaling pathways, peptide-mediated regulatory networks, transcriptional control mechanisms, and signal transduction processes. Studies have also explored its influence on molecular signaling systems, receptor-associated regulatory pathways, and peptide-dependent cellular communication mechanisms. Research applications include neuropeptide pharmacology, melanocortin pathway investigation, peptide-signaling research, transcriptional regulation studies, receptor-ligand interaction analysis, and mechanistic evaluation of peptide-mediated signaling systems.